Retirement Planning Co of New England Inc. acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 3,207 shares of the company’s stock, valued at approximately $250,000.
A number of other institutional investors have also made changes to their positions in GEHC. Pathway Financial Advisers LLC acquired a new stake in GE HealthCare Technologies in the 1st quarter valued at $25,000. BNP Paribas acquired a new stake in shares of GE HealthCare Technologies in the first quarter valued at about $30,000. Sachetta LLC bought a new stake in GE HealthCare Technologies during the fourth quarter worth about $31,000. Rise Advisors LLC boosted its position in GE HealthCare Technologies by 241.4% during the first quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after purchasing an additional 239 shares during the last quarter. Finally, Riverview Trust Co bought a new position in GE HealthCare Technologies in the first quarter valued at approximately $31,000. Institutional investors own 82.06% of the company’s stock.
Analyst Ratings Changes
A number of equities research analysts have recently issued reports on the company. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price objective on the stock. The Goldman Sachs Group started coverage on shares of GE HealthCare Technologies in a research report on Thursday, May 30th. They set a “neutral” rating and a $87.00 price target on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Finally, Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 target price on the stock. Six equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $94.58.
Insider Activity
In related news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at $1,414,377.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.27% of the stock is currently owned by company insiders.
GE HealthCare Technologies Stock Down 0.6 %
Shares of GEHC opened at $86.91 on Friday. The firm has a market cap of $39.69 billion, a P/E ratio of 25.41, a price-to-earnings-growth ratio of 3.26 and a beta of 1.17. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a 52 week low of $62.35 and a 52 week high of $94.50. The firm’s 50-day simple moving average is $83.05 and its 200 day simple moving average is $83.41.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating the consensus estimate of $0.98 by $0.02. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.92 earnings per share. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.
GE HealthCare Technologies Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date was Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Stories
- Five stocks we like better than GE HealthCare Technologies
- Investing in Travel Stocks Benefits
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Most Effectively Use the MarketBeat Earnings Screener
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- What is Insider Trading? What You Can Learn from Insider Trading
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.